Sign up to save your podcasts
Or
Share Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice
Please visit answersincme.com/JZC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in cutaneous oncology discusses the use of immunotherapy in advanced, unresectable cutaneous squamous cell carcinoma (CSCC). Upon completion of this activity, participants should be better able to: Review current evidence-based recommendations informing the treatment of patients with unresectable, locally advanced, recurrent, or metastatic CSCC; Describe the clinical profiles of immunotherapies for the treatment of patients with unresectable, locally advanced, recurrent, or metastatic CSCC; and Outline potential considerations to optimize outcomes for patients with unresectable, locally advanced, recurrent, or metastatic CSCC who are on immunotherapies.
View all episodes
By Answers in CME
5
33 ratings
Please visit answersincme.com/JZC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in cutaneous oncology discusses the use of immunotherapy in advanced, unresectable cutaneous squamous cell carcinoma (CSCC). Upon completion of this activity, participants should be better able to: Review current evidence-based recommendations informing the treatment of patients with unresectable, locally advanced, recurrent, or metastatic CSCC; Describe the clinical profiles of immunotherapies for the treatment of patients with unresectable, locally advanced, recurrent, or metastatic CSCC; and Outline potential considerations to optimize outcomes for patients with unresectable, locally advanced, recurrent, or metastatic CSCC who are on immunotherapies.
More shows like CME in Minutes: Education in Dermatology
View all
Freakonomics Radio
32,128 Listeners
Emergency Medicine Cases
548 Listeners
JDD Podcast: Ask the Investigator
66 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
The Daily
112,329 Listeners
JAMA Dermatology Author Interviews
16 Listeners
Dermasphere - The Dermatology Podcast
136 Listeners
EADV Podcast
2 Listeners
Huberman Lab
29,196 Listeners
Derms and Conditions
53 Listeners
BJD Talks
1 Listeners
Cutaneous Miscellaneous: The Dermatology Residents Podcast
6 Listeners
CME in Minutes: Education in Cardiology & Pulmonology
3 Listeners
CME in Minutes: Education in Oncology & Hematology
6 Listeners
CME in Minutes: Education in Primary Care
6 Listeners
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
5 Listeners
CME in Minutes: Education in Ophthalmology
0 Listeners
The Dermalorian Podcast
6 Listeners
The Journal of Clinical and Aesthetic Dermatology
2 Listeners
Derms on Drugs
30 Listeners